Announcements Trials
Browse Landscape

Phase

Phase 2 222Phase 3 98Phase 1/2 59Phase 1 35Phase 2/3 15Phase NA 9Phase EARLY_PHASE1 4Phase 4 4

Status

Unknown 9Completed 9Not yet recruiting 6Recruiting 4Terminated 3Active not recruiting 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3Head & Neck 1

Conditions

Breast Neoplasms 3Nasopharyngeal Neoplasms 1

Interventions

Propofol 9Sevoflurane 7Rituximab 7Specimen Handling 6Magnetic Resonance Spectroscopy 6Dexamethasone 6Trastuzumab 5Enoxaparin 5Bevacizumab 5Nivolumab 4Carboplatin 4Capecitabine 4Bupivacaine 4trametinib 3pirtobrutinib 3pembrolizumab 3dabrafenib 3atezolizumab 3apixaban 3Lenalidomide 3Indocyanine Green 3Gemcitabine 3Docetaxel 3Cyclophosphamide 3zanubrutinib 2venetoclax 2trastuzumab deruxtecan 2ribociclib 2polyethylene glycol 3350 2pertuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Recruiting × Carboplatin × Clear all
NCT06457503 2026-04-06

TRANSPARENT

Coherus Oncology, Inc.

Phase 4 Recruiting
100 enrolled
Head & Neck

Nasopharyngeal Neoplasms

NCT05420454 2022-07-01

A Study for the Neoadjuvant Treatment of Breast Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 4 Recruiting
1,576 enrolled
Breast

Breast Neoplasms

NCT05420467 2022-07-01

A Study for the Adjuvant Treatment of Breast Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 4 Recruiting
2,413 enrolled
Breast

Breast Neoplasms

NCT04136782 2021-07-20

Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer

Shengjing Hospital

Phase 4 Recruiting
110 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡